SBIR/STTR Research Award

Conductivity-weighted ultrasound for cancer detection

Award identifier f4d9ae8352119d5bba1987188ac03cda1dd568b0d1fa9cf3776b28b6ffdf0da9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$165,780

Program and phase

STTR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MAGNETUS, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Inadequate sensitivity and specificity of currently-used imaging methods for cancer screening of the breast motivates the development of new modalities capable of adding diagnostic information. EMAI (electromagnetic aco ustic imaging) is a novel imaging method which exploits tissue electrical conductivity and acoustic properties for the purposes of cancer detection. The technique relies on inducing ultrasound by electromagnetic irradiation of the tissue of interest in the radiofrequency (RF) range. This modality has advantages in the use of RF for illumination which has been well-developed in MRI, and the use of ultrasound receiving, thereby allowing for automatic image co-registration. Preliminary studies in phantoms have confirmed theoretical predictions in that the induced ultrasound signal occurs at two frequencies (the incident and twice that) and depends on conductivity gradients. In this fast-track STTR application, work is proposed to demonstrate the feasibility of EMAI as a potentially clinically useful cancer screening imaging method. The specific aims of Phase I are: 1) design and characterize conductivity phantoms, 2) build and test imager components, 3) optimize RF pulse sequence, and 4) extend previously obtain ed experimental verifications of EMAI theory. The quantitative milestones obtained during Phase I will be 1) induced ultrasound SNR as a function of conductivity gradient in phantoms at specified source-receiver distances, 2) EMAI SNR as a function of volu me of region of interest with homogeneous conductivity, 3) EMAI SNR at the RF frequency and at twice that frequency, 4) The time for signal averaging required to bring the overall SNR above 1, and 5) The temperature change in the phantom as a result of the RF power deposition. Phase II will focus on constructing a dual mode EMAI/US prototype imager with demonstration in small animals to show viability for future clinical use. Long-terms goals are to develop EMAI as a useful imaging technique for cancer scre ening, diagnosis, and monitoring. PUBLIC HEALTH RELEVANCE. The proposed project is designed to determine the feasibility of electromagnetic acoustic imaging (EMAI) for medical applications. EMAI produces conductivity-weighted ultrasound which will potentia lly improve diagnostic performance in cancer screening, and may be especially useful for screening and diagnosing breast cancer.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.